Canada to study the safety and effectiveness of biosimilars compared to reference biologic drugs Five-year study will examine real-world comparative efficacy and safety in rheumatologic conditions and inflammatory bowel disease. Does hybrid healthcare improve public health services? Lessons learned from Australia Male FPs out-earn women FPs annually by over 30%: Ontario data Study says B.C.'s housing policies mean drug users can be targeted for eviction How Big Pharma donations may influence public drug coverage A new review of 372 submissions to the Canadian Agency for Drugs or Technology in Health revealed 1896 conflicts of interest Robot simulates touch of skin to reduce pain for premature babies Toronto General makes Newsweek list of world’s top 10 hospitals CFP urges pharmacists to invest in their profession If each pharmacist in Canada donated just $25, the Foundation would have more than $1 million to fund research projects dedicated to advancing the profession. Cross-reactivity between antibacterial and nonantibacterial sulfonamides Patients with a history of sulfonamide antibiotic hypersensitivity do not need to avoid taking nonantibacterial sulfonamides Income inequalities in Indigenous groups linked to mental health issues First Previous 279 280 281 282 283 Next Last
